Literature DB >> 18021906

The tobacco epidemic in the United States.

Gary A Giovino1.   

Abstract

Tobacco use, primarily in the form of cigarettes and exposure to tobacco smoke pollution, has caused the premature deaths of more than 14 million Americans since 1964. The major diseases caused by tobacco and tobacco smoke include lung cancer, other cancers, coronary heart disease, other cardiovascular diseases, chronic respiratory diseases, pregnancy complications, and respiratory diseases in children. Per capita consumption of various tobacco products has declined substantially since 1950, with current consumption at approximately 3.7 pounds per capita. Whereas approximately two in five adults smoked cigarettes in 1965, approximately one in five did so in 2005. Several factors can influence initiation and cessation, including product factors (e.g., ventilation holes, additives, and flavorings); host factors (intention to use, level of dependence); tobacco company activities (e.g., marketing strategies, efforts to undermine public health activities); and environmental factors (e.g., peer and parental smoking, smoke-free air laws and policies). Efforts to prevent initiation, promote quitting, and protect nonsmokers should reduce exposure to pro-tobacco marketing and increase (1) the price of tobacco products, (2) protection from tobacco smoke pollution, (3) effective mass media strategies, (4) provision of effective cessation support, (5) effective regulation, and (6) litigation that holds the industry responsible for its misdeeds. Adequate implementation of effective tobacco-control strategies and useful scientific advances will help to ensure that per capita consumption decreases to the lowest level possible. The economic benefits of tobacco in our society are replaceable and they pale in comparison to the extent of human life lost.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18021906     DOI: 10.1016/j.amepre.2007.09.008

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  56 in total

1.  Smoking and quality of life among female survivors of breast, colorectal and endometrial cancers in a prospective cohort study.

Authors:  Sekwon Jang; Anna Prizment; Tufia Haddad; Kim Robien; Deann Lazovich
Journal:  J Cancer Surviv       Date:  2010-09-02       Impact factor: 4.442

2.  Large-scale genome-wide association study of Asian population reveals genetic factors in FRMD4A and other loci influencing smoking initiation and nicotine dependence.

Authors:  Dankyu Yoon; Young-Jin Kim; Wen-Yan Cui; Andrew Van der Vaart; Yoon Shin Cho; Jong-Young Lee; Jennie Z Ma; Thomas J Payne; Ming D Li; Taesung Park
Journal:  Hum Genet       Date:  2011-10-18       Impact factor: 4.132

3.  Tobacco Smoking: Facts and actions.

Authors:  Moeness M Alshishtawy
Journal:  Sultan Qaboos Univ Med J       Date:  2013-06-25

4.  Oral Dosing of Dihydromethysticin Ahead of Tobacco Carcinogen NNK Effectively Prevents Lung Tumorigenesis in A/J Mice.

Authors:  Qi Hu; Pedro Corral; Sreekanth C Narayanapillai; Pablo Leitzman; Pramod Upadhyaya; M Gerard O'Sullivan; Stephen S Hecht; Junxuan Lu; Chengguo Xing
Journal:  Chem Res Toxicol       Date:  2020-06-11       Impact factor: 3.739

5.  Clinical psychologists and smoking cessation: treatment practices and perceptions.

Authors:  Sutoidem M Akpanudo; James H Price; Timothy Jordan; Sadik Khuder; Joy A Price
Journal:  J Community Health       Date:  2009-12

Review 6.  Chronic obstructive pulmonary disease (COPD): evaluation from clinical, immunological and bacterial pathogenesis perspectives.

Authors:  Daniel J Hassett; Michael T Borchers; Ralph J Panos
Journal:  J Microbiol       Date:  2014-03-01       Impact factor: 3.422

7.  Comparative effectiveness of 5 smoking cessation pharmacotherapies in primary care clinics.

Authors:  Stevens S Smith; Danielle E McCarthy; Sandra J Japuntich; Bruce Christiansen; Megan E Piper; Douglas E Jorenby; David L Fraser; Michael C Fiore; Timothy B Baker; Thomas C Jackson
Journal:  Arch Intern Med       Date:  2009-12-14

Review 8.  Surveillance methods for identifying, characterizing, and monitoring tobacco products: potential reduced exposure products as an example.

Authors:  Richard J O'Connor; K Michael Cummings; Vaughan W Rees; Gregory N Connolly; Kaila J Norton; David Sweanor; Mark Parascandola; Dorothy K Hatsukami; Peter G Shields
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

9.  Smoking prevalence and smoking cessation services for pregnant women in Scotland.

Authors:  David M Tappin; Susan MacAskill; Linda Bauld; Douglas Eadie; Debbie Shipton; Linsey Galbraith
Journal:  Subst Abuse Treat Prev Policy       Date:  2010-01-21

10.  Reliability of self reported smoking status by pregnant women for estimating smoking prevalence: a retrospective, cross sectional study.

Authors:  Deborah Shipton; David M Tappin; Thenmalar Vadiveloo; Jennifer A Crossley; David A Aitken; Jim Chalmers
Journal:  BMJ       Date:  2009-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.